Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data

被引：0
|
作者：
Kim A. Papp
Melinda Gooderham
Ignacio Dei-Cas
Adriana LopezTello
Juan C. Garcia-Rodriguez
Carmen Yris Taveras
Azucena Hernández Rousselin
Alberto Lavieri
Mónica Maiolino
Delfina Guadalupe Villanueva Quintero
Lenka Rihakova
Mariano Salibe
Wilfran Pertuz
机构：
[1] K Papp Clinical Research and Probity Medical Research,SKiN Centre for Dermatology and Probity Medical Research
[2] Peterborough and Queen’s University,HIGA Presidente Perón, Servicio de Dermatología, Facultad Medicina UBA
[3] Psoriasis BsAs,undefined
[4] NEKI Servicios Medicos,undefined
[5] Vicente Guerreo,undefined
[6] DermaAdvance Center,undefined
[7] Hospital Regional Universitario Jose Maria Cabral Y Baez,undefined
[8] Hospital Roosevelt,undefined
[9] Calzada Roosevelt,undefined
[10] Private Clinic,undefined
[11] Consultorios Médicos Dr Bouzo,undefined
[12] Grupo Clínico CATEI (Centro de Atención en Enfermedades Inflamatorias) Sociedad Civil,undefined
[13] Novartis Pharmaceuticals Canada Inc.,undefined
[14] Novartis Argentina S.A.,undefined
[15] Novartis Pharma Logistics,undefined
[16] Inc.,undefined
[17] Panama,undefined
来源：
Dermatology and Therapy | 2023年 / 13卷
关键词：
Latin America; Plaque psoriasis; PURE registry; Real-world; Secukinumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：269 / 283
页数：14
相关论文
共 50 条
  • [1] Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data
    Papp, Kim A.
    Gooderham, Melinda
    Dei-Cas, Ignacio
    LopezTello, Adriana
    Garcia-Rodriguez, Juan C.
    Taveras, Carmen Yris
    Rousselin, Azucena Hernandez
    Lavieri, Alberto
    Maiolino, Monica
    Villanueva Quintero, Delfina Guadalupe
    Rihakova, Lenka
    Salibe, Mariano
    Pertuz, Wilfran
    DERMATOLOGY AND THERAPY, 2023, 13 (01) : 269 - 283
  • [2] Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data
    Papp, Kim A.
    Gooderham, Melinda
    Dei-Cas, Ignacio
    LopezTello, Adriana
    Garcia-Rodriguez, Juan C.
    Taveras, Carmen Yris
    Rousselin, Azucena Hernandez
    Lavieri, Alberto
    Maiolino, Monica
    Quintero, Delfina Guadalupe Villanueva
    Rihakova, Lenka
    Salibe, Mariano
    Pertuz, Wilfran
    DERMATOLOGY AND THERAPY, 2022,
  • [3] Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry
    Papp, Kim A.
    Gooderham, Melinda
    Lynde, Charles
    Brassard, Danielle
    Al-Mohammedi, Faisal
    Prajapati, Vimal H.
    Delorme, Isabelle
    Albrecht, Lorne
    Haydey, Richard
    Alam, Maryam Shayesteh
    Beecker, Jennifer
    Siddha, Sanjay
    Maguin, Marie
    Farag, Mahmoud S.
    Vieira, Antonio
    Rihakova, Lenka
    Langley, Richard G.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (07)
  • [4] Secukinumab-treated patients in the PURE registry (Patients with Moderate to Severe Chronic Plaque Psoriasis in Latin America and Canada): 12-month follow-up data
    Lynde, Charles W.
    Papp, Kim Alexander
    Gooderham, Melinda
    Alavi, Afsaneh
    Beecker, Jennifer
    Wasel, Norman
    Rampakakis, Emmanouil
    Gregry, Valerie
    Hussein, Shamiza
    Rihakova, Lenka
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB257 - AB257
  • [5] Effectiveness and safety of secukinumab in patients with moderate to severe plaque psoriasis
    Moron, R.
    Alvarez, R.
    Nieto, P.
    Garcia, C.
    Belda, S.
    Cabeza, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 378 - 378
  • [6] Secukinumab demonstrates sustained effectiveness and safety in patients with moderate to severe plaque psoriasis: 30-month follow-up data from the PURE registry
    Papp, Kim
    Gooderham, Melinda
    Haydey, Richard
    Alam, Maryam Shayesteh
    Brassard, Danielle
    Delorme, Isabelle
    Loo, Wei-Jing
    Rao, Jaggi
    Wasel, Norman
    Vieira, Antonio
    Rihakova, Lenka
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB95 - AB95
  • [7] Secukinumab treated patients in the PURE registry (patients with moderate to severe chronic plaque psoriasis in Latin America and Canada): 18 month follow up data
    Mate, E.
    Papp, K.
    Gooderham, M.
    Lynde, C.
    Langley, R.
    Alam, M.
    Beecker, J.
    Rampakakis, E.
    Boucher, A.
    Hussein, S.
    Rihakova, L.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 60 - 60
  • [8] Real-world safety of secukinumab in patients with moderate to severe chronic plaque psoriasis in Latin America and Canada: Results from the PURE registry
    Beecker, Jennifer
    Papp, Kim Alexander
    Gooderham, Melinda
    Ho, Vincent
    Lynde, Charles W.
    Robern, Michael
    Rampakakis, Emmanouil
    Boucher, Annie
    Hussein, Shamiza
    Rihakova, Lenka
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB241 - AB241
  • [9] Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry
    Melinda Gooderham
    Kim A. Papp
    Charles Lynde
    Isabelle Delorme
    Jennifer Beecker
    Lorne Albrecht
    Ignacio Dei-Cas
    Danielle Brassard
    Vimal H. Prajapati
    Antonio Vieira
    Lenka Rihakova
    Dermatology and Therapy, 2023, 13 : 535 - 553
  • [10] Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry
    Gooderham, Melinda
    Papp, Kim A.
    Lynde, Charles
    Delorme, Isabelle
    Beecker, Jennifer
    Albrecht, Lorne
    Dei-Cas, Ignacio
    Brassard, Danielle
    Prajapati, Vimal H.
    Vieira, Antonio
    Rihakova, Lenka
    DERMATOLOGY AND THERAPY, 2023, 13 (02) : 535 - 553
12345